52results about How to "Improve cough" patented technology

The present invention provides methods for treating and preventing acute exacerbations of Chronic Obstructive Pulmonary Disease. The methods particularly comprise administering to a patient have COPD a composition comprising O-desulfated heparin. The administration can be after onset of one or more symptoms indicating an exacerbation of COPD or prior to onset of such symptoms. After onset of an acute exacerbation, administration of the O-desulfated heparin is particularly beneficial for reducing the time of hospitalization of the patient and for reducing lung inflammation.

The invention relates to a Chinese medicinal preparation for treating acute upper respiratory tract infection. The Chinese medicinal preparation is prepared from the following Chinese medicinal decoction pieces in part by weight: 6 to 14 parts of notopterygium root, 6 to 12 parts of mint, 8 to 12 parts of bupleurum falcatum, 9 to 12 parts of baikal skullcap root, 8 to 12 parts of sweet wormwood, 15 to 40 parts of gypsum, 12 to 18 parts of indigowoad leaves, 10 to 15 parts of common dayflower herb and 2 to 6 parts of raw liquorice. The processes of decocting, purifying, concentrating, drying and the like are determined according to the properties of different Chinese medicinal decoction pieces and properties of effective ingredients or parts; and the extraction rate and the content of baicalin are used as indexes, and the orthogonal test is adopted for determining. Volatile oils in the mint, the sweet wormwood and the notopterygium root are effective ingredients, and are extracted respectively and added when a solid preparation is formed finally. The preparation can be used for treating fever caused by acute upper respiratory tract infection, can effectively resist virus, brings down fever quickly, and improves pharyngalgia, cough and other upper respiratory clinical symptoms.

A method of determining the status of chronic obstructive pulmonary disease (COPD) of a human that includes the steps of performing a spectral analysis of a sputum sample collected from the human; comparing the spectra produced by the analysis against a reference; and determining the status of COPD in the human based upon any determined variations.

The invention discloses a novel application of phloroglucinol, namely an application of phloroglucinol in preparing medicaments for treating bronchial asthma or chronic cough. The new application provides a new treatment way for patients with bronchial asthma and chronic cough; the phloroglucinol is used for relieving or treating the bronchial asthma and chronic cough diseases and obviously improving the cough, expectoration and asthma symptoms of the patients, has the advantages of no toxic and side effects, good treatment effect and the like, and is easily accepted by the patients.

The invention discloses a Chinese medicinal composition for treating pulmonary tuberculosis. The Chinese medicinal composition consists of the following Chinese medicinal components in parts by weight: 10 to 25 parts of radix platycodi, 10 to 20 parts of houttuynia cordata, 10 to 30 parts of radix stemonae, 5 to 15 parts of almonds, 10 to 30 parts of radix asparagi, 20 to 30 parts of radix fici hirtae, 5 to 15 parts of cooked jujube kernels, 10 to 30 parts of ophiopogon japonicus, 15 to 35 parts of roots of rehmannia, 10 to 20 parts of cortex lycii, 10 to 30 parts of anemarrhena asphodeloides, 10 to 30 parts of bletilla striata, 10 to 25 parts of lotus rhizome nodes and 5 to 15 parts of prepared licorice. According to the Chinese medicinal composition, the symptoms of cough, hemoptysis, hoarseness and the like of a patient can be obviously improved, and the effects of invigorating the lung, promoting fresh blood production, invigorating spleen, supplementing qi, moisturizing dryness by nourishing yin, preventing phlegm from forming and stopping coughing and the like can be achieved; the Chinese medicinal composition is rigorous in formula, is prepared from fewer Chinese medicinal components, can be used for specific treatment, and has good therapeutic effects on pulmonary tuberculosis.

The invention relates to an application of lyophilized hemsley rockvine root tuber in preparing a medicine used for treating AIDS. The lyophilized hemsley rockvine root tuber can be prepared into any medical preparation with traditional Chinese medicine preparation method. An effective dose for a patient a day comprises 1-300g of lyophilized hemsley rockvine root tuber. Compared with medicines prepared with commonly dried hemsley rockvine root tuber, the medicine prepared by using lyophilized hemsley rockvine root tuber has better functions in enhancing AIDS patient body immunity, inhibiting HIV virus, reducing patient clinical symptoms, and improving patient life qualities. Also, medicine resistance and toxic and side effects when HIV virus is treated by using antiretroviral can be effectively reduced.

The invention provides a Chinese medicinal preparation for treating chronic nasopharyngitis and globus hystericus, which is prepared from the raw materials including sweet wormwood, baikal skullcap root, poria cocos, dried orange peel, bitter orange, talcum powder, licorice root, bamboo shavings, pericarpium trichosanthis, thunberg fritillary bulb, peach kernels, Clematis chinensis, pilose asiabell root, reed rhizome and magnolia flower.

The invention provides an exocarpium citri rubrum buccal tablet and a preparation method thereof. The exocarpium citri rubrum buccal tablet is prepared from the following components in parts by weight: 200 to 250 parts of exocarpium citri rubrum, 61 to 85 parts of liquorice root, 98 to 115 parts of starch and dextrin and 45 to 50 parts of honey. The exocarpium citri rubrum buccal tablet provided by the invention is reasonable in formula, a pharmaceutical effect of the exocarpium citri rubrum is maintained to the maximum, a cough can be improved and phlegm can be reduced, and a bitter taste ofthe exocarpium citri rubrum can be effectively overcome on the premise that no excessive additives are added.

The invention relates to a drug, in particular to pharmaceutical composition for treating pneumoconiosis. The pharmaceutical composition comprises, by weight, 10-20 parts of radix platycodi, 1-3 parts of tilorone oxime hydrochloride, 5-10 parts of astragalus, 3-9 parts of radix glycyrrhizae and 10-20 parts of radix burpleuri. According to the pharmaceutical composition for treating the pneumoconiosis, due to the fact that part of western medicine and part of traditional Chinese medicine are adopted, the price is low, and the pharmaceutical composition for treating the pneumoconiosis can be used and popularized in a wide range; due to the fact that pure natural traditional Chinese medicine such as the astragalus and the radix glycyrrhizae is adopted, side effects of the medicine are reduced; tablet packing is adopted, a patient can take the medicine everyday conveniently and can carry the medicine conveniently for use at any time, pain of the patient during an attack is relieved, and the pharmaceutical composition for treating the pneumoconiosis is suitable for pneumoconiosis patients of all ages and at various stages; the course of treatment is short, and the effect is fast.

The invention belongs to the field of medicine, and particularly relates to application of a Jinbei preparation in resisting coronavirus. The Jinbei preparation has inhibitory effects on the novel coronavirus (2019-nCoV) and SARS-CoV, can effectively inhibit the proliferation of 2019-nCoV and SARS-CoV in in vitro tests, has high therapeutic indexes for the 2019-nCoV and SARS-CoV, can reduce the degree of CPE lesions significantly and has good effects. The 15-day clinical observation results show that the Jinbei preparation is clinically effective in treating mild and common novel coronavirus pneumonia; the combined use of the Jinbei preparation and chemicals can shorten the time for patients with novel coronavirus pneumonia to turn negative, and the time for fatigue and cough to return tonormal, reduce patient temperature fluctuations during treatment and significantly shorten the effective days of treatment for patients with novel coronavirus pneumonia.

The invention discloses food health maintenance tea granules for treating silicosis, belonging to the field of nutritional foods. The food health maintenance tea granules have a good effect and take effect quickly. The food health maintenance tea granules are prepared from the raw materials such as codonopsis pilosula, tomato, Chinese angelica, radix ophiopogonis and bulbus fritillariae cirrhosae. The food health maintenance tea granules have the functions of reinforcing healthy qi and banking up root, boosting immunity, activating blood and resolving stasis and nourishing yin and moistening lung as well as have the advantages of good effect and quick effect.

The invention discloses a traditional Chinese medicine composition used for treating a chronic obstructive pulmonary disease in the stable phase. The raw material medicine of the traditional Chinese composition is mainly composed, by weight, of 8-12 g of human placenta, 9-12 g of eucommia ulmoides, 10-12 g of fallopia multiflora, 9-12 g of walnut meat, 10-12 g of ophiopogon japonicus and 15-25 g of schisandra chinensis. Clinical case observation and treatment show that the traditional Chinese medicine composition has the obvious effects of lung releasing, kidney tonifying, body fluid regenerating, qi tonifying, yin nourishing and the like, the symptoms of cough, phlegm, pant, inflammation and the like of a patient can be improved obviously, so that the functions of removing the phlegm, resisting inflammation, relieving cough and the like are achieved, the body immunity state is adjusted, the vital capacity at the first second, the forced vital capacity and the blood oxygen content are increased, the living and life quality and the like of the patient are improved, and an obvious treatment effect is achieved on the patient suffering from the chronic obstructive pulmonary disease in the stable phase. Thus, the traditional Chinese medicine composition idealistically solves the problems which are very tough clinically.

The invention relates to a composition for treating cough, a preparation method and a preparation. The composition is prepared from the following raw materials in parts by weight: 200-500 parts of maltitol liquid or 200-500 parts of maltitol, 120-140 parts of folium eriobotryae, 15-30 parts of radix stemonae, 10-20 parts of radix peucedani, 8-10 parts of platycodon grandiflorum, 8-10 parts of cortex mori radicis and 0.10-0.20 part of menthol. The composition for treating cough is low in sugar content, good in taste, clear in product and stable in quality.

The invention discloses a traditional Chinese medicine sachet for repelling foulness. The content of the sachet comprises the following raw materials in parts by weight: 5-10 parts of rhizoma atractylodis, 10-20 parts of rhizoma atractylodis macrocephalae, 8-16 parts of schizonepeta, 6-12 parts of mint, 8-16 parts of cyrtomium fortune, 10-20 parts of wild chrysanthemum flower, 10-20 parts of fructus forsythia, 10-20 parts of platycodon grandiflorum, 6-12 parts of fructus aurantii, 6-12 parts of agastache rugosus and 6-12 parts of fortune eupatorium herb. The traditional Chinese medicine sachet for repelling foulness is developed on the basis of the conventional theory of the traditional Chinese medicine, is scientific and reasonable in formula, few in toxic and side effects, low in cost, simple to prepare, convenient to wear and high in patient compliance, and has the functions of perfuming and repelling foulness, clearing away heat and toxic materials, drying dampness and transforming turbidity, dispelling wind to relieve exogenous syndrome and facilitating lung and promoting the circulation of qi. The modern pharmacological research proves that the sachet has the functions of inhibiting virus replication, resisting bacteria and regulating specific and nonspecific immunologic functions of the body and can exert the functions at multiple points in multiple approaches; the sachet can be worn and hung in the ventilated place of the room to prevent respiratory infectious diseases such as cold and influenza.

The invention relates to honeysuckle cold granules, which are prepared from the following raw materials in parts by weight: 50-60 parts of honeysuckle, 20-30 parts of radix isatidis, 10-20 parts of semen armeniacae amarum, 10-20 parts of fructus forsythia, 20-30 parts of folium isatidis, 10-20 parts of pogostemon cablin, 10-20 parts of radix rehmanniae, 20-30 parts of mint, 30-50 parts of liquorice and 500-600 parts of ethanol water. The honeysuckle cold granules have the advantages that by adopting pure natural plants, the honeysuckle cold granules are free of an obvious toxic or side effect, safe in medication and convenient to take, are easily accepted by a patient, and are an effective drug for treating a cold.

The invention discloses a traditional Chinese medicine preparation for treating primary pulmonary tuberculosis. The preparation comprises the following traditional Chinese medicine components in parts by weight: 10-25 parts of platycodon root, 10-20 parts of heartleaf houttuynia herb, 10-30 parts of sessile stemona root, 10-30 parts of cochinchnese asparagus root, 5-15 parts of ripe Chinese date seed, 10-30 parts of unibract fritillary bulb, 10-30 parts of dwarf lilyturf tuber, 10-20 parts of Chinese wolfberry root-bark, 10-30 parts of common anemarrhena rhizome, 10-30 parts of common bletilla pseudobulb, 10-25 parts of lotus rhizome node and 5-15 parts of liquorice root. The traditional Chinese medicine preparation can achieve the effect of obviously improving the symptoms of patients, such as cough, profuse phlegm due to breathlessness, phlegm stench and hoarseness, and achieve the functions of tonifying the lung and promoting tissue regeneration, strengthening the spleen and benefiting qi, moistening the lung by nourishing yin and resolving phlegm and relieving cough. The traditional Chinese medicine preparation is precise in composition, uses fewer medicines, has specific effects and has good curative effects on pulmonary tuberculosis.

The invention discloses lung moistening and phlegm eliminating healthcare tea and a preparation method thereof. The lung moistening and phlegm eliminating healthcare tea is prepared from, by weight, 5-15 parts of white tea extracted powder, 35-45 parts of vine tea extracted powder and 45-55 parts of sealwort extracted powder. The lung moistening and phlegm eliminating healthcare tea contains important natural effective active ingredients and has the obvious immune adjustment effects of diminishing inflammation, resisting bacteria and stress, promoting healing, enhancing the immune function and the like, all the ingredients affect one another and synergistically act, the good treatment and healthcare effects are achieved, the treatment effect of relieving coughs and expectoration is remarkable, the treatment course is short, and effect taking is rapid. Meanwhile, the medicinal materials adopted in the tea are free of toxins, price is low, and the tea is suitable for being used by patients suffering from short-term and long-term coughs and expectoration.

The invention relates to a traditional Chinese medicine composition, a pharmaceutical composition as well as a preparation method thereof and a use of the traditional Chinese medicine composition and the pharmaceutical composition. The preparation materials of active ingredients of the pharmaceutical composition include the following materials in parts by weight: 28-32 parts of astragalus mongholicus and at least one of codonopsis pilosula, ginseng, radix pseudostellariae and American ginseng, 18-22 parts of Chinese angelica and at least one of prepared rehmannia root and dried rehamnnia root, 18-22 parts of dogwood and at least one of polygonum multiflorum, schisandra chinensis, placenta hominis and gecko, 14-18 parts of curcuma zedoary and at least one of rhizoma sparganii, root of red-rooted salvia and red flower, 14-18 parts of scutellaria baicalensis and at least one of polygonum cuspidatum and rhizoma anemarrhenae, 18-22 parts of radix asteris and at least one of radix stemonae and flos farfarae, 8-12 parts of fritillaria thunbergii and 8-12 parts of liquorices.

The invention provides a solid culture medium for production of cordyceps powder and a production method of cordyceps powder, and belongs to the technical field of cordyceps powder. The production method of the cordyceps powder comprises the following steps of initially inoculating cordyceps into a liquid culture medium to perform basic culture, so as to obtain a basic culture liquid; transferringthe basic culture liquid into the other liquid culture medium to perform basic culture for the second time, so as to obtain a fermenting seed liquid; inoculating the fermenting seed liquid into a solid culture medium to perform amplification culture, and collecting the cordyceps powder, wherein the cordyceps is hirsutella sinensis. The production method of the cordyceps powder using corn flour asthe main raw material of the culture medium has the advantages that the large-scale industrialized production is easy, and the cordyceps powder can be quickly, efficiently, green and safely produced;the cordyceps powder produced by the method has good effect on treating the bronchitis and the cough caused by deficiency of the lung and kidney.

The invention discloses feed for resisting viral respiratory diseases of animals by utilizing houttuynia cordata. The feed comprises the following raw materials in parts by weight: 240-280 parts of soybeans, 180-220 parts of wheat, 50-60 parts of green gram starch, 40-50 parts of white fish meal, 30-40 parts of pork liver powder, 10-13 parts of crab shell powder, 25-30 parts of houttuynia cordata, 15-25 parts of maize leaf, 20-25 parts of folium mori, 5-10 parts of lavender, 20-25 parts of salsola collina, 15-20 parts of day lily, 3-5 parts of green onion, 0.5-1 part of salt, 15-18 parts of wax gourd, 3-4 parts of mushrooms, 2-3 parts of dried turnip, 2-3 parts of laver, 1-2 parts of greenish lily flower petals, 0.3-0.6 part of peanut oil, 0.5-1 part of sesame paste and 1-2 parts of animal nutrient. The feed disclosed by the invention has obvious effects of inhibiting and killing viruses and bacteria, has an excellent effect of treating the viral respiratory diseases of animals and can effectively improve the symptoms such as cough, high fever, emaciation, expiratory dyspnea and diarrhea of animals, the death rate of the animals is reduced, and the breeding benefits are improved.